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Abstract
Background: Oral mucosa expansion before ridge augmentation is a procedure to
reduce soft tissue exposure and to improve bone graft density and volume after aug-
mentation. This study explored a novel, shapeable hydrogel tissue expander (HTE) in
intraoral sites that had undergone previous expansion and surgery.
Methods: Nine beagle dogs had all premolar teeth extracted and adjacent alveolar
bone reduced. After at least 3 months healing hydrogels were placed at 4 sites in each
dog: maxilla and mandible, right and left. After 6 weeks of expansion, the hydrogels
were removed and measured for volume expansion and physical condition. Punch
biopsies were taken of the expanded oral mucosa. After 3 months, a second hydrogel
insertion was performed at each of the same sites. After this second expansion cycle,
volume and hydrogel condition were recorded. Three dogs received ultrasound imag-
ing of the hydrogels during the second expansion. Necropsy specimens were taken of
both expanded and non-expanded oral mucosa.
Results:Within 2 weeks after HTE insertion in both first and second insertions, blood
flow returned to the pre-insertion level. The first and second insertions resulted in
linear oral mucosa gain of 8.13 mm, and 6.44 mm, respectively. First and second
insertion hydrogels erupted from 4% of the first expansion sites, and 3% of the second
expansion sites. There was no directional migration of the expanding hydrogel at any
site. Histology found little inflammatory reaction to any hydrogel implant.
Conclusion: Oral mucosa can be consistently and successfully expanded before bone
graft for ridge augmentation even at sites with a history of prior surgeries.
© Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
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1 INTRODUCTION
Resorption of alveolar bone is common in patients follow-
ing tooth extraction. The bone volume loss amounts to 40–
60% within the first 3 years, and after 3 years continues at
a rate of 0.25% to 0.5% loss per year.1 Vertical ridge aug-
mentation restores lost alveolar bone but often results in
clinical problems and is unpredictable, largely because of
problems with soft tissue management.2 Surgeons frequently
face the challenge of working with poorly vascularized oral
mucosa using current “split-thickness” flap techniques.3 This
ischemic mucosa causes exposure of grafted bone to microbes
of the oral cavity, resulting in reduction or total loss of the sus-
ceptible graft. Previous surgery, oral trauma, chronic infec-
tions, and history of tobacco use are factors contributing to
decline in the mucosal vascularity and ability to heal.4–6 In
addition, tension introduced by sutures on a fragile mucosal
flap further invites necrosis and bone graft exposure.7–9 These
undesirable outcomes associated with vertical ridge augmen-
tation with an exposed bone graft have a high probability of
leading to reduction of up to 6 times final volume as compared
with unexposed bone graft.10 Exposure often leads to reduc-
tion or complete loss of the bone graft.11–19 It is estimated
that up to 45% of attempted ridge augmentations are lost or
significantly compromised with the current surgical technique
of “split-thickness” mucosa when placing bone grafts,14,19 as
compared with only 4% bone graft exposure when using a
tissue expander before bone grafting.20 There is a significant
need for tissue expanders in the dental field.21
Tissue expansion, widely used for skin applications, has
increasingly been shown to offer promising results also for
expansion of oral mucosa.21 These devices are commonly
uaed as a means to increase skin surface area under a
constant pressure via viscoelastic forces. Application of
an optimal expansion rate and force, results in new, fully
vascularized tissue,22 which can be applied in a wide variety
of surgical procedures such as, breast reconstruction, autol-
ogous skin transplantation in burn victims, or vertical ridge
augmentation.
Recently we have reported a study assessing tissue perfu-
sion of oral mucosa following insertion of a novel shapeable
hydrogel tissue expander (HTE).22 To validate the use of this
HTE in an intraoral setting that resembles clinical applica-
tions, we used a beagle dog model to simulate the alveolar
bone resorption that often occurs in patients following tooth
loss.
The rate and force of expansion of soft tissue must match
not only the anatomic site23 but also accommodate any tissue
alterations incurred by previous surgery or trauma. A common
clinical scenario requires ridge augmentation at a site with a
history of multiple surgeries or injury. This study uniquely
explores the ability to expand tissues comparing two succes-
sive surgical insertions of HTE at the same sites to better
understand the clinical challenges associated with intraoral
scarred tissue expansion in preparation for ridge augmenta-
tion. Our model relied on two successive expander insertions
at the same site. In our previous publication, we reported on
only the second insertion results representing the common
clinical situation of a previous surgical procedure or trauma.22
2 MATERIALS AND METHODS
2.1 Canine model of oral mucosa expansion
using hydrogel tissue expander
All animal studies were approved by the Indiana Univer-
sity Institutional Animal Care and Use Committee. Nine
adult female Beagle dogs (Marshall BioResources, North
Rose, NY), 13 months old, were subject to premolar tooth
extraction and reduction of alveolar bone. Each animal was
allowed to recover for at least 3 months before the inser-
tion of the first, shapeable hydrophilic polymer: hydrogel tis-
sue expander (HTE) (Restiex, Akina, Inc., West Lafayette,
IN). The hydrogel in this study is comprised of chemically
crosslinked poly(ethylene glycol) (PEG) and poly(lactide-co-
glycolide) (PLGA) polymers connected by acrylate linkages.
PLGA is a biodegradable and biocompatible polymer with a
well-established history of clinical safety.24
Four HTEs were implanted in four oral mucosa sites
for each dog: right and left maxilla and mandible. During
the first insertion, five variations of HTEs were tested in
36 sites. Each expander (initial dimensions: approximately
5 mm wide × 20 mm long × 3 mm thick end-tapered semi-
cylinder) was comprised of an acrylate-crosslinked mixture
of polyester and polyethylene glycol that varied based on
percent compositions and molecular weight of each compo-
nent to achieve varying expansion properties as previously
described.24 For example, the type C and type E expanders
were both comprised of 65% (w/w) PLGA-PEG-PLGA-
diacrylate, 22% (w/w) PEG (600 Da)-diacrylate, 9% (w/w)
ethylene glycol-diacrylate, and 4% (w/w) Polylactide (Mw
∼30 kDa)-diacrylate. For type “C” the PLGA-PEG-PLGA
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TABLE 1 Expansion metrics
Animals Insertions
Number of
sites
Volume and
mechanical strength Migration Perfusion Histology
9 dogs 1st insertion 24 (“E”
hydrogel)
Photographs Laser surface
scan
Laser speckle
imaging
3 punch biopsies
per site
2nd insertion 32 (“C”
hydrogel)
Photographs,
ultrasound
Laser surface
scan
Laser speckle
imaging
7 punch biopsies
per site
diacrylate was 5000-1000-5000 Da for each block whereas
the more hydrophilic type “E” was 3500-1000-3500 Da for
each block. Initial screening with 4 sites was performed with
expander types “A” to “E.” This screening identified type E
as a promising candidate for initial implantation and, as such,
an additional 20 sites were performed for first insertion using
type “E”. After 6 weeks of expansion and monitoring, the
hydrogels were removed, biopsies were collected, and all sites
were allowed to heal for another 3 months. Following the
recovery period, a second insertion of HTEs was completed.
Formulation “E” was used for the second insertion in the ini-
tial dog, but was lost 3 days after insertion because of the
force and rate of expansion. These properties of the HTE did
not match the physical requirements of the scarred mucosa
for re-implantation. By design, the “C” formulation expanded
at a slower rate than the “E” formulation and was used for
the remainder of the test animals after this loss. The second
implantations were performed at the exact same sites as the
first implantations. After 6 weeks of hydrogel assessment, the
devices were removed, tissue biopsies were collected and the
animals were euthanized. Table 1 is an overview of our study.
2.2 Surgical technique
Surgical placement of the HTEs was achieved via “C”-shaped
full-thickness incision characterized by a convex arc directed
toward the vestibule. A full-thickness pouch created in this
manner allowed for insertion of the device, and closure of the
incision was performed with interrupted horizontal mattress
sutures.
2.3 Volume expansion and movement
assessment
A digital camera (Nikon D90 camera, Nikon Corporation,
Shinagawa, Tokyo, Japan) with a 105 mm f/2.8 lens (Nikon
AF-S VR Micro-Nikkor 105 mm f/2.8G IF-ED lens, Nikon
Corporation, Shinagawa, Tokyo, Japan) was used to photo-
graph each of the HTE before insertion and immediately after
removal, with a ruler in the frame of the photograph to aid in
measurement calibration, as previously described. Image soft-
ware (MicroSuite FIVE, B & B Microscopes Ltd, Pittsburgh,
PA), was used to assess the dimensional change. The physical
condition of the expanded hydrogels was recorded and judged
as either “whole,” “fragmented,” or “crumbled.”
Migration of the expanding hydrogel was assessed by a
laser surface scan (660 nm V2 laser probe, Class 2 M)
(FaroArm, FARO Technologies, Lake Mary, FL ). This tech-
nique allows precise 3-dimensional time-delineated assess-
ment of the implanted expander in relation to a fixed point.
The analysis was performed on oral mucosa for each of the
first insertion sites and for all sites in six of the nine dogs
undergoing the second insertion. The chronological sequence
at each predetermined scanning time point was sensitive to
any migration of the HTE. Migration was assayed using 3D
analysis software (Geomagic Qualify, 3D Systems, Rock Hill,
SC). The “measure distance” feature in the software was used
to determine the distance between the anterior edge of the
expander bulge and the base of the dog's canine tooth. This
distancewas determined for the same implantation in the same
animal at each scanned time point and measured in millime-
ters. Because the tooth is a static point, a consistent change in
distance over time would represent migration.
2.4 Tissue perfusion assessment using laser
speckle contrast imager
To assess blood perfusion of oral mucosa we employed a
laser speckle contrast imager (LSI), Class 1 laser (moorFLPI-
2 blood flow image, Moor Instruments, UK) at low resolu-
tion/high speed image acquisition rate (25 Hz). The scans
were performed once a week, under sedation. Each of the two
tissue regions of interest (ROI) were assessed for a duration
of 1 minute. ROI-1 represents area of mucosa in contact with
hydrogel, whereas ROI-2 represents an adjacent area that had
not been surgically manipulated. Details of the tissue perfu-
sion assessment are found in our previous publication.22
2.5 Histologic tissue analysis
The expanders were allowed to expand in the mucosa tissue
for 6 weeks or until secondary endpoint of tissue expander
self-removal (i.e., eruption through the expanding mucosa).
After the 6-week expansion, the expanded hydrogel was
removed, biopsies were taken, and the mucosa was resutured.
Immediately after hydrogel removal on Day 42 of the
first and second insertions, biopsies were taken using a
round 2 mm dermatology punch biopsy knife. It was pre-
supposed that after 90 days of healing these small biopsies
would have minimal influence on the second hydrogel implant
expansion parameters. For both first and second insertions,
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F IGURE 1 Removal of expanded hydrogel. A, HTE, after 6 weeks of expansion. B, Just after removal of expanded HTE, maxillary site. Blue
arrows point to a thin fibrous capsule that covered the expanded HTE. Yellow arrow points to punch biopsy of very thin, uniform fibrous capsule that
formed between bone and inserted HTE. C, Marked increase in new, vascular soft tissue for vertical ridge augmentation. D, Expanded compared
with unexpanded HTE
two-millimeter punch biopsies were taken through the ante-
rior (rostral) and posterior (caudal) zones of the hydrogel
expansion site, and into the periosteum at the deepest inter-
nal extent of the expanded hydrogel. These biopsies demon-
strated the fibrous capsule that enclosed each expanded hydro-
gel. The second insertion took the same biopsy sites as the
first insertion, but added 4 additional biopsy sites of unex-
panded mucosa next to the expanded oral mucosa. Each
biopsy was performed in a manner that included the submu-
cosal connective tissue close to the hydrogel to reveal any
possible inflammatory reaction, fibrosis, neovascularization,
or retained hydrogel particles resulting from the hydrogel
insertion, expansion, and removal. Each biopsy was placed
in neutral buffered formalin and fixed for at least 24 hours.
Fixed biopsy cores were embedded in paraffin oriented so that
sections included both surface and deep tissues of the cores.
Histologic sections 4 microns in thickness were stained with
hematoxylin and eosin, and with Masson's trichrome stain.
Each section was graded for vascularity of the mucosal flap,
extent of histiocytic infiltration around the gel, and thickness
of the fibrous capsule. In addition, each section was exam-
ined for the presence or absence of retained hydrogel, chronic
inflammatory cells, acute inflammatory cells, and proper ori-
entation of the biopsy core to permit full thickness evalua-
tion. These data were recorded in an Excel spreadsheet for
statistical evaluation.
2.6 Statistical analysis
Mixed-model ANOVA tests were used to analyze data points
obtained for each dog and for each of the surgical sites.
A P value of 0.05 was considered statistically significant.
Standard error of the mean (SEM) is shown in the graphs.
3 RESULTS
3.1 Hydrogel expansion and migration
Each of the sites receiving HTE tolerated the material well,
allowing for creation of a clinically relevant amount of
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TABLE 2 Expansion results
Insertion 1st 2nd
Hydrogel tested “E” “C”
Number sites tested 24 32
Eruption rate 4% 3%
Hydrogel expansion Linear 50% 32%
Volume 135% 107%
Mucosa gain Linear 8.13 mm 6.44 mm
additional tissue. Figure 1A illustrates typical results of
expanded oral mucosa. The capsule was incised with a sharp
dissection and the expander was easily removed in entirety
with no apparent attachment to the surrounding tissue, as
shown in Figure 1B. A large amount of mucosa was created,
as demonstrated in Figure 1C. This method was used for all
second HTE insertions. Figure 1D compares an unexpanded
with an expanded HTE, where at the time of insertion the
expanded HTE was at the same dimension and volume as the
unexpanded HTE.
To assess the extent of HTE migration, we used the laser
surface scanner to record topographic parameters relative to a
constant point of reference (canine tooth). The type “E” first
insertion measurements matched the type “C” second inser-
tionmeasurements. No specificmigratory trendwas observed,
that is, the HTE was not consistently drifting towards one
direction over time, despite significant hydrogel expansion.
Statistical analysis of the data points confirmed the null
hypothesis of no hydrogel migration.
Table 2 summarizes the outcomes of the first and second
insertion in respect to the physical condition of the retrieved
hydrogel. During the process of first insertion, the majority of
sites received the “E” HTE. Other formulae were tried early
during the study, however, type “E” appeared to have optimal
clinical characteristics of strength and degree of expansion
without premature eruption of the mucosa by the expanding
hydrogel. Only one out of 24 hydrogels was lost (accounting
for 4% rate of HTE loss). For the second insertion we opted
for the more slowly expanding “C” formulation. From 32 sites
that received hydrogel “C,” only one was lost (accounting for
a 3% rate of HTE loss).
Table 2 also summarizes the linear and volume expansion
data for both insertions. HTE “E” has a higher gain of volume
(135% vs. 107%) and linear expansion (50% vs 32%), and as a
result produces a larger mucosal gain than type “C” (8.13 mm
vs. 6.44 mm).
3.2 Tissue perfusion in the primary
and secondary insertion of HTE
Blood perfusion of oral mucosa during the first two weeks
following HTE insertion, has been characterized by hypo-
and subsequent hyper-perfusion, as the manipulated tissue
F IGURE 2 Perfusion of oral mucosa during 6 weeks of
expansion, comparison of first and second insertions
recovers from the incision and insertion of a foreign body.
Following the initial two weeks, we observed the blood flow
returning to baseline. Our previous study concentrated in
depth on perfusion of expanding oral mucosa following the
2nd insertion.22 The tissue perfusion during the first HTE
insertion was indistinguishable from oral mucosa perfusion
following the second tissue expansion. Figure 2 compares the
oral mucosa perfusion during 6 weeks of expansion for both
the first and second insertions.
3.3 Dimensional ratio of HTE during
expansion
Figure 3 shows the ultrasound measured dimensional changes
from the second insertion's last 3 dogs. These data indi-
cate no trend for dimensional ratios (ratio of length/height,
height/width, length/width) over 6 weeks of expansion. The
symmetry of the hydrogel expansion during swelling in vivo
preserved the initial shape of the HTE as it enlarged. The
swelling was unisotropic, a necessary feature for a reshapable
expander to maintain proper contours regardless of how it is
cut.
3.4 Tissue histology of the primary and
secondary insertion of HTE
Histologic assessment of expanded oral mucosa showed a
thin, uniform capsule located in the submucosal tissue above
the nerves and muscle. The capsule appeared to be thin with
slightly compact fibrous connective tissue and absence of his-
tiocytic or granulomatous inflammation of the cavity lining.
Inflammation was rarely found in the biopsies.
At euthanasia, no dog had palpable lymphadenopathy in
the head or neck. Histology found no sign of fibrous cap-
sule thickening or inflammatory response to micro-particles
of hydrogel adjacent to the HTE in some biopsies. These
acellular fragments shrunk during processing and dehydra-
tion, leaving connective tissue spaces no larger than 50 μm.
These micro-particles, apparently in the process of gradual
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absorption by the surrounding tissue were found in 19% of
the sites (Figure 4A–D). As reported in our previous publi-
cation, no hydrogel micro-particles were found in tissues of
unexpanded mucosa apart from the HTE cavity, indicating no
spread of hydrogel from the site of primary insertion.22
4 DISCUSSION
Expansion of oral mucosa continues to be a challenging,
but necessary, surgical procedure to assist with vertical ridge
augmentation and other dental procedures requiring mucosal
flaps. In this study, we have shown that a shapeable hydro-
gel tissue expander is effective for flap generation both in tis-
sue with minimal surgical manipulation or previous trauma,
as well as in tissue previously subjected to surgery.
Initial studies of HTE insertion revealed what we believe
to be the optimal approach to hydrogel placement in oral
mucosa. It is best to insert a self-enlarging expansion device
via creation of a pouch beneath the full-thickness oral mucosa.
It appeared preferable to have the convexity of the inci-
sion pointing toward the vestibule. As a result, the HTE
expanded toward the vestibule instead of erupting into the
mouth. Although the HTE used in this study may be shaped
by trimming into almost any configuration, we limited the
scope to adjusting only the length of the hydrogel cylinder
at the time of insertion. The slow, continuous, symmetri-
cal expansion of HTE used in this study, when compared to
episodic bolus expansion with a silicone rubber balloon tissue
expander, caused no disruption of the incision, compromise of
the circulation, or pronounced fibro-inflammatory response.
Initially, an incision for HTE removal was made in the
same location as the insertion incision. However, this nar-
row opening led to “crushing” and “crumbling” of some
expanded hydrogels during removal. To better simulate a
clinical application of the expander and to avoid possible
incomplete removal of the HTE, the technique was modified.
A crestal incision similar to the one used for bone grafting not
only allowed retrieval of the intact hydrogel but also exposed
a strong mucosal flap supported by the HTE-associated thin
fibrous capsule as shown in Figure 1B.
The study was designed to closely simulate clinical situ-
ations faced in dental practice. On removal of the expanded
HTE there was a 45% symmetrical gain in volume. The
optimal swelling kinetics were characterized by initial 70%
swelling during the first few days relative to the original
volume, followed by slow 30% increase in volume over the
next 4–6 weeks. The physicochemical properties of the HTE
resulted in formation of a fibrous capsule thinner than the cap-
sules typically surrounding silicone implants. The fibrous cap-
sule in our study had no adverse impact on the surrounding
tissue and showed no inclination to contract as it matured. We
postulate that formation of the thin fibrous capsule, possibly
within the first two weeks post insertion,25 may have secured
the expanding hydrogel and prevented it from migrating. The
lack of migration, supported by FaroArm laser surface scan-
ner (FaroArm, FARO Technologies, Lake Mary, FL) data,
would permit precise localization of the expanded mucosa in
clinical applications.
Implanting foreign material into the human body elicits
an immune response. However, hydrophobic materials elicit
a stronger immune response than hydrophilic materials.26
Hydrophilic PEG-based hydrogels were previously found to
encourage early-stage inflammation/healing but have very
limited foreign-body reaction or chronic inflammation.27 The
hydrophilic PEG polymers are known to prohibit protein
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F IGURE 4 Histology of possible particles of HTE in the fibrous capsule. All particles identified were less than 50 μm in length. A, Overview
of specimen. Square is area enlarged in panel B. H&E stain. B, Possible particles of hydrogel shown with black arrows. H&E stain. C, Overview of
specimen. Masson's Trichrome stain. D, Possible particles of hydrogel with black arrows. Trichrome stain
attachment and activation, thereby reducing clotting28 and
immune response.29 This protein non-attachment property is
more pronounced with copolymers such as poloxamers30 and
PEG-PLGA.31 Similarly PEG-fumarate biodegradable hydro-
gels have a mild foreign-body reaction, and form a thin fibrous
capsule withminimal inflammation. It has been suggested that
this fibrous capsule reduces access of the hydrogel breakdown
products to the rest of the tissue.32 As long as the fibrous
capsule is intact, hydrogel migration will be minimal, as dis-
covered in our study. Further, symmetrical expansion of HTE
should invite applications of this expansion method in clinical
circumstances where an unusual shape or configuration of the
flap is required.
Inadequate tissue perfusion is an important cause for hydro-
gel eruption that may be as significant as the type of incision
and HTE placement. Expansion that is too rapid results in
ischemia, followed by necrosis of the expanding oral mucosa.
Oral mucosa with a history of previous surgeries or injury,
poses significant challenges for expansion because of irre-
versible changes in the tissue affecting its elasticity. Although
oralmucosa forms less scar than skin, the healing process does
show histologic fibrosis.5,6 Oral mucosa split-thickness flaps
with fenestration result in scars lasting at least 140 days, even
when there is no exposure of the alveolar bone.33 An immuno-
histochemical assessment of human oral mucosa comparing
smokers and non-smokers found the same vascular density in
both, but smaller and less abundant larger blood vessels nour-
ished the mucosa of smokers.34 Smoking status of the patient,
age, and any history of previous surgery affects the quality
and elasticity of oral mucosa. Changes in mucosal physiologic
properties pose an additional challenge for hydrophilic salta-
tory balloon type expanders. We have previously described in
more detail successful outcomes of oral tissue expansion fol-
lowing secondary HTE insertion.22 Assessment of tissue per-
fusion following the insertion of both type “E” and type “C”
HTE revealed no significant difference between them, despite
different characteristics of volume and rate of expansion, and
prior tissue manipulation for each of the devices.
A critical histologic assessment of the oral mucosa
revealed possible “shedding” of micro-hydrogel particles,
which would result in residual hydrogel fragments in the
fibrous capsule. This process has also been shown to occur
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with silicone.35 The micro-particles of hydrogel underwent
shrinkage during processing and dehydration. Nevertheless,
the original size in vivo could be seen by microscopic cavities
in the fibrous capsule, which were usually less than 50 μm
in the maximum dimension. No histologic inflammatory
reaction was seen near these lacunae. Neither lacunae, nor the
dehydrated hydrogel particles in them, were found in control
histology specimens of oral mucosa taken from unexpanded
tissue. The control biopsies were near, but not in contact with
the HTE, indicating that hydrogel micro-particles do not
migrate.22 Such “shed” hydrogel particles are more prevalent
and larger in rodents, indicating that species differences as
well as the more rapidly expanding formulations used in the
rat study may be a factor in this phenomenon.24
Throughout the current study with dogs, all the hydrogel
expanders removed through crestal incisions were intact and
easily removed with no apparent attachment to the consis-
tently thin, uniform fibrous capsule. The final metabolites of
HTE (by cleavage of all alky-ester bonds) are lactic acid,
glycolic acid, PEG (∼700–1000 Da), ethylene glycol, and
poly(acrylic acid). Lactic acid enters the tricarboxylic acid
cycle and is metabolized to carbon dioxide. Glycolic acid is
either excreted unchanged in the kidney or it enters the tri-
carboxylic acid cycle.36 Ethylene glycol (very small quantity)
is metabolized to glycolic acid. PEG in HTE is well below
the molecular weight threshhold of urinary clearance.37 The
excretion of poly(acrylic acid) is slow, through the liver and
spleen, but has been reported to be well tolerated in doses
above those encountered in practical HTE applications.38
Time to absolute degradation may be extensive, but in the
absence of biocompatibility issues, as shown in this study,
excretion may not represent a clinical problem. The hydro-
gel in HTE not only can be reshaped by the surgeon, but
also appears to have fewer biocompatibility and pharmaco-
logic concerns than silicone surfaces used with other tissue
expanders.39
4.1 Summary
The thin, uniform fibrous capsule found in our study, when
compared with other implants such as silicone rubber, appears
to result from expansile pressure and continuous swelling of
the hydrogel, without toxic or inflammatory influences. The
HTE fibrous capsule did not become thicker or denser over
time, as often found with silicone rubber implants. A thick-
ened capsule may limit expansion of mucosa and affect the
formation of new tissue. Based on this observation, we used
an HTE with modified swelling kinetics showing delayed
and slowed expansion for the second implant because of
anticipated stiffness of the previously surgically manipulated
tissues.
Tissue expanders increase available tissue in a region due
to the biological processes of tissue “creep” (or “biological
stretch”) that allow epithelia to increase in surface area under
a constant pressure due to viscoelastic forces. However, the
body reacts to different expander devices in a variety of ways,
including foreign-body reaction, temporary hyperpigmenta-
tion, and neo-vascularization. Nevertheless, regardless of the
device, with appropriate expansion force and timing, there is
generation of new, fully vascular tissue.40
Oral mucosa is more delicate and difficult to expand
than skin. In our experience, excessively rapid expansion of
hydrogels erupted through the mucosa and were removed
or lost. The process involved steps of ischemia, necrosis,
and finally eruption and loss of the device. This occurred
both with early HTE prototypes and with another, commer-
cially obtained hydrogel tissue expander (Osmed, Ilmenau,
Germany). Understanding the relationship between hydrogel
properties, tissue biomechanical properties and surgical
technique are critical for obtaining excellent in vivo results.
The hydrogel formula and surgical design described here
have been used successfully with uneventful and successful
healing for gingival mucosa expansion in dogs.
5 CONCLUSION
We present a comparison of oral mucosa expansion during
the first and second insertion at the same sites, using HTE
tissue expanders with 2 different specifications in the rate and
force of expansion. Tissue perfusion was well preserved, the
device did not migrate within tissue, there was no apparent
toxicity or bio-incompatibility, and the result was adequate
additional tissue surface area suitable for ridge augmentation.
The accrued tissue would be suitable to cover a bone graft
during ridge augmentation without split-thickness flaps. We
report a shapeable, self-contained hydrogel tissue expander
with a success rate of about 96% for first insertion and near
97% for re-operative second insertions at the same sites.
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